Deacetylation of Transcription Factors in Carcinogenesis

Area of Science:

• Epigenetics
• Molecular Biology
• Oncology

Background:

• Reversible Nε-lysine acetylation/deacetylation is a key post-translational modification (PTM) regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs).
• This epigenetic process significantly influences carcinogenesis by altering protein properties and functions.
• Transcription factors, including tumor suppressors and oncoproteins, are targets of this modification, affecting cell signaling pathways.

Purpose of the Study:

• To review the critical role of HDACs in cancer development.
• To elucidate how HDACs influence transcription factor activity and signaling pathways in cancer.
• To highlight the therapeutic potential of targeting epigenetic modifications in cancer treatment.

Main Methods:

• Literature review focused on HDACs, epigenetics, and cancer.
• Analysis of studies detailing HDACs' impact on transcription factors and cell signaling.
• Synthesis of information on HDACs' role in tumor progression, metastasis, and drug resistance.

Main Results:

• HDACs deacetylate target proteins, leading to altered expression of genes involved in cell cycle and apoptosis.
• Dysregulation of HDACs contributes to tumor growth, invasion, and acquired drug resistance.
• Targeting HDACs offers a promising therapeutic strategy for various cancers.

Conclusions:

• HDACs play a significant role in carcinogenesis by modulating transcription factor function and signaling pathways.
• Understanding HDACs' epigenetic influence is crucial for developing novel cancer therapies.
• Epigenetic modifications represent a vital area for clinical intervention in cancer treatment.